Dr. Osman Sharifi, Postdoctoral California Institute for Regenerative Medicine (CIRM) Fellow and CEO of 2C Bioscience, joined CIRH's Executive Director Mohammad Sediq Hazratzai to discuss the prevalence and epigenetics of Autism Spectrum Disorder (ASD), sharing insights into its impact and underlying factors.

This video is in Dari and includes a presentation followed by a Q&A session. The auto-generated translation is available by clicking the Subtitles/Closed Captions option.